ACERCA DE ESTE EPISODIO
In this episode of Bladder Cancer Matters, host and survivor Rick Bangs sits down with ImmunityBio's Chief Medical Officer, Dr. Bobby Reddy, for a fascinating, hopeful look at the future of bladder cancer treatment.
They unpack how next-generation immunotherapies like ANKTIVA—paired with innovative approaches to BCG—are reshaping care for patients, especially those with limited options, while also tackling real-world challenges like ongoing BCG shortages.
Dr. Reddy breaks down the science in a way that's accessible, highlighting how activating the body's own immune system could lead to longer-lasting responses and even help patients avoid more invasive treatments. Tune in to this conversation about progress and possibility.
Inglés
Estados Unidos
TRANSCRIPCIÓN 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
BUSCAR EPISODIOS ANTERIORES
Buscar episodios anteriores de Bladder Cancer Matters.
OTROS EPISODIOS EN ESTE PODCAST
In this powerful episode of Bladder Cancer Matters, a podcast by the Bladder Cancer Advocacy Network, host and survivor Rick Bangs sits down with Vanderbilt nurse Bree Duncan to explore a groundbreaking new role dedicated solely to supporting women with bladder cancer.
Created through the vision …
In this episode of Bladder Cancer Matters, host Rick Bangs sits down with urologic oncologist Dr. Minhaj Siddiqui to break down a critical but often overlooked gap in bladder cancer care—and what it means for patients.
They explore how non-muscle-invasive bladder cancer is treated, why a simple st…
In this episode of Bladder Cancer Matters, host Rick Bangs speaks with Dr. Josefa Briceno of AstraZeneca about why bladder cancer care may be at a true turning point. From exploring immunotherapy earlier in the disease journey — even around the time of surgery — to strengthening collaboration betwe…
In this powerful episode of Bladder Cancer Matters, Rick Bangs sits down with Mike Vasallo, a high school assistant principal diagnosed with early-onset bladder cancer at 46 who turned fear and uncertainty into purpose.
Mike shares his raw, honest journey through diagnosis, treatment and recovery—…
Descargo de responsabilidad: El podcast y el arte incluidos en esta página son de Bladder Cancer Advocacy Network, que es propiedad de su propietario y no está afiliado ni respaldado por Listen Notes, Inc.
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
